TRESIVAC

The Tresivac Injections is a combination of Measles, Mumps, and Rubella vaccine that protects against three infectious diseases: measles, mumps, and rubella. It is given as a routine childhood vaccination in many countries. Measles is a highly contagious viral infection that can cause serious complications, including pneumonia, encephalitis (brain swelling), and even death. Mumps is a viral infection primarily affecting the salivary glands, causing swelling and pain in the jaw area. It can also lead to complications like meningitis (inflammation of the brain layer), deafness, and inflammation of the testicles or ovaries. Rubella is a viral infection that causes a rash and fever. While it is generally a mild illness, it can have severe consequences if contracted by pregnant women, as it can lead to congenital rubella syndrome in the unborn child.

The Tresivac Injection is considered safe and well-tolerated. Like any vaccine, it can have mild side effects such as pain or swelling at the injection site, low-grade fever, or a rash. Serious side effects are rare. Vaccination against measles, mumps, and rubella is important for individual protection and for creating herd immunity (immunity in the population). Suppose an individual has had a severe allergic reaction (such as anaphylaxis) to a previous dose or any of its components. In that case, they should not receive further doses of the vaccine. People with severe immunodeficiency, such as certain types of cancer, HIV/AIDS with low CD4 counts (type of immune cell), or those receiving immunosuppressive treatments like chemotherapy or high-dose steroids, should not receive it. If an individual has received blood products or immunoglobulins (antibodies) within the past few months, the Tresivac Injections may need to be delayed. Pregnant women should not take it.